Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD

This study has been completed.
Purdue Pharma LP
Information provided by (Responsible Party):
Rhodes Pharmaceuticals, L.P. Identifier:
First received: June 14, 2014
Last updated: July 7, 2015
Last verified: July 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2015
  Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)